Skip to content

TURP; Complications and Outpatient Care

Bipolar Transurethral Resection of the Prostate; Complications and Possibility to do as Outpatient Procedure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03959917
Enrollment
50
Registered
2019-05-22
Start date
2019-05-15
Completion date
2020-09-30
Last updated
2019-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Keywords

prostate, resection, incontinence, erectile dysfunction

Brief summary

This study aims to investigate the impact of transurethral prostate resection in regard to complications. These are direct surgical complications, such as bleeding, infection and readmissions, as well as the long term complications as incontinence and impotence. Also, the study aims to investigate if selected cases of patients could be performed as outpatient surgery, thereby reducing cost.

Detailed description

Transuretral prostate resection (TUR P) is a common procedure to relieve voiding problems in men. After the introduction of bipolar resection with saline, the serious complication of transurethral resection syndrome (i.e. acute hypo-natremia) has been eradicated. The post surgical care is generally a couple of days inhospital care. The reson for this, is the risk of clot formation and in rare cases post surgical infection. However, in selected cases, outpatient surgery has been performed with encouraging results. However, the technique has not been spread widely. The use of ambulatory surgery would reduce the direct cost of the procedure, thereby increasing it´s availability. Also, complications in contemporary TUR P in the modern era (outside of the selected patients of clinical trials) is lacking. The information of complications that can be expected is therefore an important for patient counseling. In some studies, the use of incontinence pads after TUR P is more than 15%, which is important to reliably ascertain if this is holds true.

Interventions

Surgical removal of benign prostatic tissue

Sponsors

Umeå University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

* Planned for transurethral resection of the prostate (TUR P)

Exclusion criteria

* No consent to participate

Design outcomes

Primary

MeasureTime frame
Proportion of patients able to be discharged the day of surgeryOne day
Proportion of patients readmitted to hospital the first day of surgeryOne day

Secondary

MeasureTime frameDescription
Readmission rates within 30 days of surgery30 days
Change in IPSS score6 monthsInternational prostate symptom score, range 0-35
Proportion catheter free6 months
Complications30 daysClavien Dindo Classification
Number of patients with cancer in surgical specimen6 monthsPathological confirmed prostate cancer, all Gleasson Grades (6-10)

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026